Status:
COMPLETED
Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A
Lead Sponsor:
Ipsen
Conditions:
Spasticity
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to describe the long term use of Botulinum Neurotoxin Type A (BoNT-A) in adult subjects affected with upper and/or lower limb spasticity who received treatment with BoNT-A for ...
Eligibility Criteria
Inclusion
- Adult aged ≥18 years old at the time of the first BoNT-A injection
- Diagnosed with spasticity with any cause (excluded CP)
- Treated with a minimum of three BoNT-A treatment cycles for upper limb spasticity (ULS) and/or lower limb spasticity (LLS)
- With follow up data available in the subject's medical record
- Provision of written informed consent form, to the extent required according to applicable national local regulations for a retrospective, non-interventional study
Exclusion
- Treatments and assessments were performed at more than one centre
Key Trial Info
Start Date :
July 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04340336
Start Date
July 21 2020
End Date
October 31 2021
Last Update
March 16 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Ubaldo Del Carro
Milan, Italy, 20132
2
Marecello Esposito
Milan, Italy, 80131
3
Morena Giovannelli
Roma, Italy, 00189